Cyclic AMP inhibits production of interleukin-6 and migration in human vascular smooth muscle cells

Journal of Surgical Research

Volumn 109, Issue 1, 2003, Pages 57-61

  Newman, Walter H ^a   Castresana, Manuel R ^a   Webb, Jerry G ^b   Wang, Zhongbiao ^a  

^a MERCER UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

Cyclic AMP; Interleukin 6; Smooth muscle cell migration, tumor necrosis factor

Indexed keywords

8 BROMO CYCLIC AMP; ANTIBODY; CYCLIC AMP; FORSKOLIN; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CELL CULTURE; CELL MIGRATION; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; CYTOKINE PRODUCTION; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; MOLECULAR BIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RADIOIMMUNOASSAY; SAPHENOUS VEIN; SMOOTH MUSCLE FIBER; VASCULAR SMOOTH MUSCLE;

EID: 0037289168     PISSN: 00224804     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-4804(02)00038-0     Document Type: Article

References (23)

1. Rus H.G., Niclescu F., Vlaicu R. Tumor necrosis factor-alpha in human arterial wall with atherosclerosis. Atherosclerosis. 89:1991;247.
2. Tanaka H., Sukhova G., Schwartz D., Libby P. Proliferating arterial smooth muscle cells after balloon injury express TNF-α but not Interleukin-1 or basic fibroblast growth factor. Arterioscler. Thromb. Vasc. Biol. 16:1996;12.
3. Rectenwald J.E., Moldawer L.L., Huber T.S., Seeger J.M., Ozaki C.K. Direct evidence for cytokine involvement in neointimal hyperplasia. Circulation. 102:2000;1697.
4. Clausell N., Molossi S., Sett S., Rabinovitch M. In vivo blockade of tumor necrosis factor-alpha in cholesterol-fed rabbits after cardiac transplant inhibits acute coronary artery neointimal formation. Circulation. 89:1994;2768.
5. Wang Z., Castresana M.R., Newman W.H. NF-κB is required for TNF-α-directed smooth muscle cell migration. FEBS Lett. 508:2001;360.
6. Galis Z.S., Muszynski M., Sukhova G.K., Simon-Morrissey E., Libby P. Enhanced expression of vascular matrix metalloproteinases induced in vitro by cytokines and in regions of human atherosclerotic lesions. Ann. NY Acad. Sci. 748:1995;501.
7. Galis Z.S., Muszynski M., Sukhova G.K., Simon-Morrissey E., Unemori E.N., Lark M.W., Libby P. Cytokine-stimulated human vascular smooth muscle cells synthesize a complement of enzymes required for extracellular matrix digestion. Circ. Res. 75:1994;158.
8. Montminy M. Transcriptional regulation by cyclic AMP. Annu. Rev. Biochem. 66:1997;807.
9. Newman W.H., Castresana M.R., Webb J.G., Wang Z., Warejcka D.J. Stimulation of β-adrenergic receptors inhibits release of tumor necrosis factor-α from the isolated rat heart. Crit. Care Med. 28:2000;3593.
10. Newman W.H., Castresana M.R., Webb J.G., Detmer K., Wang Z. Isoproterenol inhibits transcription of cardiac cytokine genes induced by reactive oxygen intermediates. Anesthesiology. 96:2002;947.
11. Seki J., Koyama N., Kovach N.L., Yednock T., Clowes A.W., Harlan J.M. Regulation of beta1-integrin function in cultured human vascular smooth muscle cells. Circ. Res. 78:1996;596.
12. Brooker G.J., Harper J.F., Terasaki W.L., Moylan R.D. Radioimmunoassay of cyclic AMP and cyclic GMP. Adv. Cyclic Nucleotide Res. 10:1979;1.
13. Suma H. Arterial grafts in coronary bypass surgery. Ann. Thorac. Cardiovasc. Surg. 5:1999;141.
14. Bryan A.J., Angelini G.D. The biology of saphenous vein graft occlusion Etiology and strategies for prevention . Curr. Opin. Cardiol. 9:1994;641.
15. Carpenter C.L. Actin cytoskeleton and cell signaling. Crit. Care Med. 28:(Suppl):2001;N94.
16. Jovinge S., Hultgärdh-Nilsson A., Regnström J., Nilsson J. Tumor necrosis factor-α activates smooth muscle cell migration in culture and is expressed in balloon-injured rat aorta. Arterioscler. Thromb. Vasc. Biol. 17:1997;490.
17. Kossakowska A.E., Edwards D.R., Prusinkiewicz C., Zang M.C., Guo D., Urbanski S.J., Grogan T., Marquez L.A., Janowska-Wieczorek A. Interleukin-6 regulation of matrix metalloproteinase (MMP-2 and MMP-9) and tissue inhibitor of metalloprotienase (TIMP-1) expression in malignant non-Hodgkin's lymphomas. Blood. 94:1999;2080.
18. Cohen G., Tamariz M.G., Sever J.Y., Liaghati N., Guru V., Christakis G.T., Bhatnagar G., Cutrara C., Abouzahr L., Goldman B.S., Fremes S.E. The radial artery versus the saphenous vein graft in contemporary CABG A case-matched study . Ann. Thorac. Surg. 71:2001;180.
19. Yasunari K., Kohno M., Hasuma T., Horio T., Kano H., Yokokawa K., Minami M., Yoshikawa J. Dopamine as a novel antimigration and antiproliferative factor of vascular smooth muscle cells through dopamine D1-like receptors. Arterioscler. Thromb. Vasc. Biol. 17:1997;3164.
20. Horio T., Kohno M., Kano H., Ikeda M., Yasunari K., Yokokawa K., Minami M., Takeda T. Adrenomedullin as a novel antimigration factor of vascular smooth muscle cells. Circ. Res. 77:1995;660.
21. Chaldakov G.N., Nabika T., Nara Y., Yamori Y. Cyclic AMP- and cytochalasin B-induced arborization in cultured aortic smooth muscle cells Its cytopharmacological characterization . Cell. Tissue Res. 255:1989;435.
22. Nabika T., Chaldakov G.N., Nara Y., Yamori Y. Phorbol 12-myristate 13-acetate prevents isoproterenol-induced morphological change in cultured vascular smooth muscle cells. Exp. Cell Res. 178:1988;358.
23. Klemm D.J., Watson P.A., Frid M.G., Dempsey E.C., Schaak J., Colton L.A., Nesterova A., Stenmark K.R., Reusch J.E.-B. cAMP response element-binding protein content is a molecular determinant of smooth muscle cell proliferation and migration. J. Biol. Chem. 276:2001;46132.